NCT06827652

Brief Summary

The Triple-A Barcelona Study (TABS), is a new hospital-based longitudinal study recruiting consecutive individuals with Abdominal Aortic Aneurysm (AAA) in Barcelona. Individuals that have at least one measurement of the abdominal aortic diameter, either by computed tomography scan or by ultrasound, along with anthropometric, clinical information, and blood samples for most follow-up visits are recruited.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
32mo left

Started Oct 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Oct 2020Dec 2028

Study Start

First participant enrolled

October 5, 2020

Completed
4.3 years until next milestone

First Submitted

Initial submission to the registry

January 23, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 14, 2025

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

8.2 years

First QC Date

January 23, 2025

Last Update Submit

February 13, 2025

Conditions

Abdominal Aortic Aneurysm

Keywords

Aneurysm, Aorta, risk

Outcome Measures

Primary Outcomes (1)

  • Abdominal Aortic diameter

    Diameter in mm

    baseline, through study completion (every 2 years on average), pre-surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

\- Individuals with a diagnosis of AAA visiting at Hospital de Sant Pau or Hospital del Mar in Barcelona.

You may qualify if:

  • clinical diagnosis of abdominal aortic aneurysm
  • infrarenal abdominal aortic diameter greater than 30 mm

You may not qualify if:

  • Type B dissections that progress to AAA
  • saccular aneurysms
  • mycotic aneurysms
  • visceral aneurysms
  • thoracic aneurysms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de la Santa Creu i Sant Pau

Barcelona, Catalonia, 08041, Spain

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Extracted DNA and RNA extracted from blood cells, along with plasma samples will be retained.

MeSH Terms

Conditions

Aortic Aneurysm, AbdominalAneurysm

Condition Hierarchy (Ancestors)

Aortic AneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Study Officials

  • Maria Sabater-Lleal, PhD

    RESEARCH INSTITUTE/HOSP/SANTA CREU/PAU

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maria Sabater-Lleal, PhD

CONTACT

+34932919000msabater@santpau.cat

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2025

First Posted

February 14, 2025

Study Start

October 5, 2020

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

February 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations

ES(1)